Kura Oncology is positioning ziftomenib (KOMZIFTI) as a combination backbone in AML, not just a relapsed/refractory ...

This first-in-class differentiated approach will be highlighted during a Featured Research Session entitled Alzheimer's therapy: mechanisms beyond amyloidROCHESTER, N.Y., July 08, 2026 (GLOBE NEWSWIRE ...

Creatine, the common muscle-building supplement, may help improve depression symptoms, new research suggests. A systematic ...

A man the Department of Justice calls a "gun-toting drug dealer" hid guns in random spots around his home, including in the ...

Conventional wisdom holds that targeting the best-connected individuals in a social network is an effective way to nudge a ...

Oracle (NYSE: ORCL) was founded as a software company in 1977, before transitioning first to cloud computing and later to ...

South Korea's KOSPI index enters bear market territory, falling over 20% from its June peak as Samsung and SK Hynix sell off ...

Certain gut bacteria may influence the odds of developing MS, in part by altering the activity of specific immune cells, ...

During a live event, Brittany Siontis, MD, a sarcoma oncologist at Mayo Clinic, and participants examined how to choose between the systemic options for progressive desmoid tumors ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the 26-week results (Part B) from its second ongoing ...

HouseCalls has been accused of generating trumped up diagnoses to hike UnitedHealth’s Medicare reimbursement. But the review ...

Discusses Accelerated FDA Approval of TRUTAKNA for IgA Nephropathy July 7, 2026 4:30 PM EDTCompany ParticipantsSean Grant ...